Meeder Asset Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-399
| Closed | -$3K | – | 2380 |
|
|
2020
Q1 | $3K | Sell |
399
-811
| -67% | -$6.1K | ﹤0.01% | 1980 |
|
|
2019
Q4 | $9K | Sell |
1,210
-2,240
| -65% | -$16.7K | ﹤0.01% | 1594 |
|
|
2019
Q3 | $41K | Buy |
3,450
+3,225
| +1,433% | +$38.3K | ﹤0.01% | 1075 |
|
|
2019
Q2 | $3K | Sell |
225
-419
| -65% | -$5.59K | ﹤0.01% | 1803 |
|
|
2019
Q1 | $8K | Sell |
644
-273
| -30% | -$3.39K | ﹤0.01% | 1300 |
|
|
2018
Q4 | $6K | Buy |
917
+112
| +14% | +$733 | ﹤0.01% | 1376 |
|
|
2018
Q3 | $8K | Buy |
805
+540
| +204% | +$5.37K | ﹤0.01% | 1215 |
|
|
2018
Q2 | $1.78K | Sell |
265
-78
| -23% | -$524 | ﹤0.01% | 1431 |
|
|
2018
Q1 | $2K | Sell |
343
-58
| -14% | -$338 | ﹤0.01% | 1389 |
|
|
2017
Q4 | $8K | Buy |
+401
| New | +$8K | ﹤0.01% | 1197 |
|
|
2017
Q3 | – | Sell |
-79
| Closed | -$1K | – | 1733 |
|
|
2017
Q2 | $1K | Buy |
79
+25
| +46% | +$316 | ﹤0.01% | 1542 |
|
|
2017
Q1 | $1K | Buy |
+54
| New | +$1K | ﹤0.01% | 1543 |
|